Advances in glomerular filtration rate-estimating equations

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 3, 2010, Pages 298-307

  Stevens, Lesley A ^a   Padala, Smita ^a   Levey, Andrew S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Creatinine; Cystatin; Glomerular filtration rate; Prognosis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CREATININE; CYSTATIN C; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; ASIAN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DOSE KIDNEY FUNCTION RELATION; ETHNIC GROUP; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY INJURY; LABORATORY TEST; MEASUREMENT; MEDICAL SPECIALIST; MORTALITY; OBESITY; OUTCOMES RESEARCH; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT;

CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES;

EID: 77951489481     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32833893e2     Document Type: Review

References (77)

1. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089-2100.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
3. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050-1065.
4. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
5. Coresh J, Astor B, Sarnak M. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2004; 13:73-81. (Pubitemid 39069902)
6. Hsu CY, Ordonez JD, Chertow GM, et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008; 74:101-107.
7. Seliger SL, Zhan M, Hsu VD, et al. Chronic kidney disease adversely influences patient safety. J Am Soc Nephrol 2008; 19:2414-2419.
8. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52:5-18.
9. Australian and New Zealand Society of Nephrology (ANZSN) Website. www.nephrology.edu.au. [Accessed 19 December 2008]
10. The National Health Insurance Fund of Independent Professionals. Amendment to the National Convention of Directors of Private Laboratories for Medical Analysis; 2004. http://www.admi.net/jo/20030227/SANS0320604X.html. [Accessed 22 December 2008]
11. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005; 183:138-141.
12. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009; 75:1009-1014.
13. Coresh J, Stevens LA, Levey AS. Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant 2008; 23:1122-1125.
14. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008; 23:1117-1121.
15. GlassockRJ, WinearlsC. CKD: fiction not fact. Nephrol Dial Transplant 2008; 23:2695-2696; author reply 2696-2699.
16. Eckardt KU, Berns JS, Rocco MV, et al. Definition and classification of CKD: the debate should be about patient prognosis: a position statement from KDOQI and KDIGO. Am J Kidney Dis 2009; 53:915-920.
17. Miller WG. Estimating glomerular filtration rate. Clin Chem Lab Med 2009; 47:1017-1019.
18. National Kidney Disease Education Program. Estimation of kidney function for medication dosage prescriptions in adults; 2009. http://www.nkdep.nih.gov/. [Accessed August 4 2009]
19. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009; 20:2305-2313.
20. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483.
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
22. Botev R, Mallie JP, Couchoud C, et al. Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol 2009; 4:899-906.
23. Rigalleau V, Beauvieux MC, Le Moigne F, et al. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Diabetes Metab 2008; 34:482-489.
24. Fontsere N, Bonal J, Salinas I, et al. Is the new Mayo Clinic quadratic equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients? Diabetes Care 2008; 31:2265-2267.
25. Chudleigh RA, Ollerton RL, Dunseath G, et al. Performance of the revised '175' Modification of Diet in Renal Disease equation in patients with type 2 diabetes. Diabetologia 2008; 51:1714-1718.
26. Sebasky M, Kukla A, Leister E, et al. Appraisal of GFR-estimating equations following kidney donation. Am J Kidney Dis 2009; 53:1050-1058.
27. Saleem M, Florkowski CM, George PM. Comparison of the Mayo Clinic quadratic equation with the Modification of Diet in Renal Disease equation and radionuclide glomerular filtration rate in a clinical setting. Nephrology (Carlton) 2008; 13:684-688.
28. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-992.
29. Li H, Zhang X, Xu G, et al. Determination of reference intervals for creatinine and evaluation of creatinine-based estimating equation for Chinese patients with chronic kidney disease. Clin Chim Acta 2009; 403 (1-2):87-91.
30. Delanaye P, Cavalier E, Radermecker RP, et al. Estimation of GFR bydifferent creatinine-and cystatin-C-based equations in anorexia nervosa. Clin Nephrol 2009; 71:482-491.
31. Beringer PM, Hidayat L, Heed A, et al. GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. J Cyst Fibros 2009; 8:19-25.
32. Sterner G, Bjork J, Carlson J, et al. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate. Scand J Urol Nephrol 2009; 43:242-249.
33. Willems D, Wolff F, Mekhali F, et al. Cystatin C for early detection of renal impairment in diabetes. Clin Biochem 2009; 42 (1-2):108-110.
34. Stevens LA, Coresh J, Schmid CH, etal. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51:395-406.
35. Rule AD, Bergstralh EJ,SlezakJM, et al. Glomerularfiltration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006; 69:399-405.
36. Larsson A, Malm J, Grubb A, et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/min. Scand J Clin Lab Invest 2004; 64:25-30.
37. Tidman M, Sjostrom P, Jones I. Plasma cystatin C for estimating residual GFR (rGFR) in dialysis patients. Nephrol Dial Transplant 2008; 23:1072-1073; author reply 1073.
38. Grubb A, Nyman U, Bjork J, et al. Simple cystatin C-based prediction equations for glomerularfiltration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005; 51:1420-1431.
39. Stevens LA, Zhang Y, Schmid CH. Evaluating the performance of equations for estimating glomerular filtration rate. J Nephrol 2008; 21:797-807.
40. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens 2006; 15:276-284.
41. Rule AD, Larson TS, Bergstralh EJ, etal. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141:929-937.
42. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
43. Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007; 11:41-50. (Pubitemid 46474965)
44. Rule AD, Teo BW. GFR estimation in Japan and China: what accounts for the difference? Am J Kidney Dis 2009; 53:932-935.
45. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40:221-226.
46. Grubb AO. Cystatin C: properties and use as diagnostic marker. Adv Clin Chem 2000; 35:63-99.
47. Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerularfiltration rate. Curr Opin Nephrol Hypertens 2006; 15:610-616.
48. Knight EL, Verhave JC, Spiegelman D, etal. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65:1416-1421.
49. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75:652-660.
50. Grubb A, Bjork J, Lindstrom V, et al. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 2005; 65:153-162.
51. Astor BC, Levey AS, Stevens LA, et al. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 2009; 20:2214-2222.
52. Foley RN, Wang C, Snyder JJ, Collins AJ. Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol 2009; 4:965-972.
53. Levey AS, Atkins R, Coresh J, etal. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72:247-259.
54. Xie D, Joffe M, Brunelli S, et al. A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. Clin J Am Soc Nephrol 2008; 3:1332-1338.
55. Lee D, Levin A, Roger SD, et al. Longitudinal analysis of performance of estimated glomerularfiltration rate as renal function declines in chronic kidney disease. Nephrol Dial Transplant 2009; 24:109-116.
56. Abraham AG, Schwartz GJ, Furth S, et al. Longitudinal formulas to estimate GFR in children with CKD. Clin J Am Soc Nephrol 2009; 4:1724-1730.
57. Jain AK, McLeod I, Huo C, et al. When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int 2009; 76:318-323.
58. Stevens LA, Levey AS. Impact of reporting estimated glomerular filtration rate: it's not just about us. Kidney Int 2009; 76:245-247.
59. Noble E, Johnson DW, Gray N, etal. The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant 2008; 23:3845-3850.
60. Richards N, Harris K, Whitfield M, etal. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant 2008; 23:549-555.
61. Food and Drug Administration. Guidance for industry: pharmacokinetics in patients with impaired renal function-study design, data analysis, and impact on dosing and labeling. Rockville, MD: U.S. Department of Health and Human Services; 1998.
62. Stevens LA, Nolin TD, Richardson MM, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009; 54:33-42.
63. de Lemos ML, Hsieh T, Hamata L, et al. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies. Gynecol Oncol 2006; 103:1063-1069.
64. Bookstaver PB, Johnson JW, McCoy TP, et al. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination. Ann Pharmacother 2008; 42:1758-1765.
65. Wargo KA, Eiland EH 3rd, Hamm W, etal. Comparison of the modification of diet in renal disease and Cockcroft-Gault equations for antimicrobial dosage adjustments. Ann Pharmacother 2006; 40 (7-8):1248-1253.
66. Gill J, Malyuk R, DjurdjevO, etal. Use of GFR equations to adjust drug doses in an elderly multiethnic group: a cautionary tale. Nephrol Dial Transplant 2007; 22:2894-2899.
67. Golik M, Lawrence K. Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cock-croft-Gault and modification of diet in renal disease. Pharmacotherapy 2008; 28:1125-1132.
68. Melloni C, Peterson ED, Chen AY, et al. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008; 51:991-996.
69. Moranville MP, Jennings HR. Implications of using modification of diet in renal disease versus Cockcroft-Gault equations for renal dosing adjustments. Am J Health Syst Pharm 2009; 66:154-161.
70. Hermsen ED, Maiefski M, Florescu MC, et al. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials. Pharmacotherapy 2009; 29:649-655.
71. Stevens LA, Levey AS. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther 2009; 86:465-467.
72. Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41:47-55. (Pubitemid 36044403)
73. Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63:1121-1129. (Pubitemid 36315592)
74. Stevens LA, Levey AS. Chronic kidney disease in the elderly: how to assess risk. N Engl J Med 2005; 352:2122-2124.
75. Coresh J. CKD prognosis: beyond the traditional outcomes. Am J Kidney Dis 2009; 54:1-3.
76. Matsushito K, Selvin E, Bash L, et al. Risk implications of the new CKD-EPI equations as compared to the MDRD Study equation for estimated GFR: the ARIC Study. Am J Kidney Dis 2010. [Epub ahead of print].
77. White S, Polkinghorne K, Atkins R, et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD-EPI and MDRD Study GFR estimating equations: the AusDiab Study. Am J Kidney Dis 2010. [Epub ahead of print].